complications of semaglutide Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Alaa Abd-Elsayed | Weight loss

It works by mimicking GLP-1 hormone activity, which reduces appetite, slows digestion, and improves insulin release

Although the details of the mechanism are not yet fully understood, researchers have found that the primary source of GLP-1 in the brain is preproglucagon (PPG) neurons in the NTS

The Wegovy Pill (Oral Semaglutide): Form: A daily tablet (historically known as Rybelsus for diabetes, but high-dose oral formulations for weight loss are the new standard)

Liver-humanized mice: a translational strategy to study metabolic disorders

She also noted that more studies are needed comparing the effects on other health outcomes beyond weight loss

How should I handle calories